Connect Biopharma Holdings LtdCNTB

Connect Biopharma Holdings Ltd Award Timing Disclosure Disclosure

10-KFiled Mar 31, 20261 min read
The Compensation Committee has historically approved grants of annual equity awards in March of each year as part of our annual compensation cycle. The Compensation Committee shifted the timing of such approvals to December of each year beginning in 2024 to better align with the timing of the Company’s annual compensation cycle. The timing of any equity grants to newly-hired employees, including our executive officers, or in
connection with promotions, or other non-routine grants is generally tied to the event giving rise to the award (such as an individual’s commencement of employment or promotion effective date). Any such grants to executive officers are generally approved at meetings of the Committee or the Board, except under extraordinary circumstances.

Historical Timeline

Fiscal YearFiled
2025Mar 31, 2026Showing above
2024Mar 31, 2025

Other Available Disclosures

Income TaxesRevenueFair ValueSegmentsCommitmentsStock CompensationNew StandardsPay vs Performance